CoChat

Divalproex Sodium in Substance Abusers With Mood Disorder

Albanese, Mark J., Clodfelter, Reynolds C., Khantzian, Edward J. · 2000 · The Journal of Clinical Psychiatry

The DOI matches its Crossref record.

Abstract

BACKGROUND: Substance abuse is a common comorbid illness in patients with mood disorders. Little has been written about the pharmacologic treatment of patients with affective lability and co-occurring substance abuse, however. The following report will describe clinical experience using divalproex sodium in substance-abusing patients with mood disorder. METHOD: Twenty patients admitted to an intermediate-care inpatient substance abuse program were diagnosed with comorbid mood disorder (according to DSM-IV criteria) and treated with divalproex sodium in an open-label, naturalistic trial with no blind. All patients were followed clinically and were assessed using the Clinical Global Impressions scale (CGI) and laboratory studies. RESULTS: Seven patients referred while on divalproex treatment continued to exhibit improved mood. Eleven others had at least 1 week of follow-up, and 10 of these also showed improvement. In 13 cases, divalproex was used safely with other psychiatric medications. Two patients complained of slight tremor, 1 of whom was also taking fluoxetine. Fifteen of 17 patients in whom biochemistry and hematology laboratory studies were completed had unremarkable results; 2 other patients had pretreatment abnormalities, which worsened over the course of treatment. Mean plasma valproate level was 58.53 microg/mL. Mean length of follow-up was 38 days. Mean period of abstinence prior to starting medication was 48 days. Some patients reported decreased cravings, and, by self-report, all patients remained abstinent. CONCLUSION: This report suggests that divalproex sodium is efficacious and safe, both alone and in combination with other psychiatric medications, in treating substance-abusing patients with mood disorder.

Overview

Integrity signals

Registry

Crossref · 10.4088/jcp.v61n1205

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cited by

See all 40

Metadata

Authors
Albanese, M. J., Clodfelter, R. C., & Khantzian, E. J.
Affiliations
Commonwealth of Massachusetts (US)
Venue
The Journal of Clinical Psychiatry
Published
2000-12-15
Volume
61
Issue
12
Pages
916-921
ISSN
0160-6689 (ISSN-L)
OpenAlex
W2028878833
Cited by
40
References
0
Citations by year
2026: 1 · 2023: 1 · 2021: 2 · 2018: 3 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 1 · 2012: 1
FWCI
1.40
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
divalproex sodium, valproic acid, substance abuse, mood disorders, emotional lability, comorbidities, bipolar disorder, drug safety, combination pharmacotherapy, alcohol craving, abstinence
MeSH terms
Adult, Anticonvulsants, Bipolar Disorder, Depressive Disorder, Drug Therapy, Combination, Follow-Up Studies, Hospitalization, Humans, Male, Middle Aged, Psychotropic Drugs, Valproic Acid, Comorbidity, Substance Abuse Treatment Centers, Panic Disorder, Behavior, Addictive, Treatment Outcome, Mood Disorders, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Divalproex Sodium in Substance Abusers With Mood Disorder. https://app.cochat.ai/papers/10.4088/jcp.v61n1205
The paper
Albanese, M. J., Clodfelter, R. C., & Khantzian, E. J. (2000). Divalproex Sodium in Substance Abusers With Mood Disorder. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v61n1205

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.